Your Location:
Home >
Browse articles >
Induction of anti-hepatoma immunity by recombinant retrovirus expressing B7-1 /B7-2 costimulatory molecules
Updated:2026-03-12
    • Induction of anti-hepatoma immunity by recombinant retrovirus expressing B7-1 /B7-2 costimulatory molecules

    • Military Medical Research Vol. 0, Issue 2, Pages: 138-142(2000)

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

3

Views

22

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research
Ionizable drug delivery systems for efficient and selective gene therapy
Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Related Author

Xiao Yang
Jian Wang
Jing-Ping Xu
Jun Wang
Zhen-Hua Li
Wen-Zhen Du
Yu-Qi Zhang
Ran-Ran Guo

Related Institution

Yaneng BIOScience (Shenzhen) Co., Ltd.
State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences, Beijing Institute of Lifeomics
Department of Health Technology and Informatics, the Hong Kong Polytechnic University
Department of Laboratory Medicine, Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University
Advanced Research Institute of Multidisciplinary Science, School of Life Science, School of Medical Technology, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology